COMMUNIQUÉ DE PRESSE

par Eckert & Ziegler Strahlen- Und Medizintechnik AG (isin : DE0005659700)

Annual General Meeting of Eckert & Ziegler SE Approves Split-Off of Pentixapharm AG

EQS-News: Eckert & Ziegler SE / Key word(s): AGM/EGM
Annual General Meeting of Eckert & Ziegler SE Approves Split-Off of Pentixapharm AG

26.06.2024 / 16:27 CET/CEST
The issuer is solely responsible for the content of this announcement.


Berlin, June 26, 2024. The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) today resolved to split-off Pentixapharm AG from Eckert & Ziegler SE and to distribute a dividend of EUR 0.05 per share for the 2023 financial year.

As in the previous year, the Annual General Meeting was held as an in-person event at Eckert & Ziegler SE's headquarters in Berlin. A total of 57.6% of the company's share capital was represented.

The detailed voting results of the Annual General Meeting and the presentation by the Chairman of the Executive Board are published on the Eckert & Ziegler SE website:
https://www.ezag.com/home/investors/annual_general_meeting/

About Eckert & Ziegler
Eckert & Ziegler SE with more than 1.000 employees is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse.
Contributing to saving lives.

Your contact:
Eckert & Ziegler SE, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com 



26.06.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language:English
Company:Eckert & Ziegler SE
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone:+49 30 941084-138
Fax:+49 30 941084-0
Internet:www.ezag.de
ISIN:DE0005659700
WKN:565970
Indices:SDAX, TecDax,
Listed:Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID:1933989

 
End of NewsEQS News Service

1933989  26.06.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1933989&application_name=news&site_id=symex~~~af100301-a623-4c64-8f3d-90fc88eca9e6
Voir toutes les actualités de Eckert & Ziegler Strahlen- Und Medizintechnik AG